Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 48 Neoplasms 43 Depression 31 Fatigue 30 Prostatic Neoplasms 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Lymphoma, Follicular 18 Lymphoma, Large B-Cell, Diffuse 17 Multiple Myeloma 16 Carcinoma, Non-Small-Cell Lung 16 Lymphoma, Non-Hodgkin 15 Lung Neoplasms 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Lymphoma, Mantle-Cell 14 Leukemia, Myeloid, Acute 14 Hodgkin Disease 14 Colorectal Neoplasms 14 Burkitt Lymphoma 14 Anxiety Disorders 14 Pain 13 Lymphoma, B-Cell, Marginal Zone 13 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma 11 Leukemia, Myeloid, Chronic-Phase 11 Head and Neck Neoplasms 11 Blast Crisis 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10 Leukemia, Myeloid, Accelerated Phase 10 Leukemia, Hairy Cell 10

Interventions

HhAntag691 25 Imiquimod 12 Biopsy 12 sonidegib 11 Aminolevulinic Acid 9 cemiplimab 8 Photochemotherapy 8 Nivolumab 8 methyl 5-aminolevulinate 7 Mohs Surgery 7 1-phenyl-3,3-dimethyltriazene 7 Tomography, Optical Coherence 6 Surgical Procedures, Operative 6 Specimen Handling 5 Radiotherapy 5 Itraconazole 5 pembrolizumab 4 daromun 4 Microscopy, Confocal 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 Curettage 4 Standard of Care 3 Niacinamide 3 IPI-926 3 CTLA-4 Antigen 3 3-ingenyl angelate 3 tazarotene 2 talimogene laherparepvec 2 relatlimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Therapeutics × Clear all

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡